PubMed:9497493
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 26-31 | protein | denotes | MCP-1 |
| T2 | 201-210 | protein | denotes | cytokines |
| T3 | 221-237 | protein | denotes | interferon-gamma |
| T4 | 239-248 | protein | denotes | IFN-gamma |
| T5 | 269-290 | protein | denotes | chemokine superfamily |
| T6 | 385-394 | protein | denotes | IFN-gamma |
| T7 | 405-425 | protein | denotes | class II MHC antigen |
| T8 | 457-490 | protein | denotes | intercellular adhesion molecule-1 |
| T9 | 495-521 | cell_line | denotes | cultured endothelial cells |
| T10 | 634-643 | protein | denotes | IFN-gamma |
| T11 | 899-929 | protein | denotes | monocyte chemotactic peptide-1 |
| T12 | 931-936 | protein | denotes | MCP-1 |
| T13 | 941-950 | protein | denotes | chemokine |
| T14 | 1070-1079 | protein | denotes | IFN-gamma |
| T15 | 1169-1175 | protein | denotes | STAT-1 |
| T16 | 1210-1227 | cell_type | denotes | endothelial cells |
| T17 | 1233-1242 | protein | denotes | IFN-gamma |
| T18 | 1261-1266 | protein | denotes | MCP-1 |
| T19 | 1334-1343 | protein | denotes | IFN-gamma |
| T20 | 1458-1463 | protein | denotes | MCP-1 |
| T21 | 1512-1541 | protein | denotes | phosphatidylinositol 3-kinase |
| T22 | 1585-1607 | cell_type | denotes | mononuclear leucocytes |
| T23 | 1618-1627 | protein | denotes | chemokine |
| T24 | 1767-1772 | protein | denotes | MCP-1 |
| T25 | 1849-1858 | protein | denotes | IFN-gamma |
| T26 | 1886-1891 | protein | denotes | MCP-1 |
| T27 | 1906-1932 | cell_line | denotes | cultured endothelial cells |
| T28 | 2034-2039 | protein | denotes | MCP-1 |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 26-31 | NP | denotes | MCP-1 |
| C2 | 47-54 | NP | denotes | heparin |
| C3 | 105-112 | NP | denotes | Heparin |
| C5 | 116-153 | NP | denotes | a polyanionic glycosaminoglycan (GAG) |
| C6 | 154-158 | NP | denotes | that |
| C7 | 221-249 | NP | denotes | interferon-gamma (IFN-gamma) |
| C4 | 116-290 | NP | denotes | a polyanionic glycosaminoglycan (GAG) that can bind with high affinity to a range of cytokines including interferon-gamma (IFN-gamma) and members of the chemokine superfamily |
| C8 | 292-300 | NP | denotes | This GAG |
| C9 | 385-394 | NP | denotes | IFN-gamma |
| C10 | 495-521 | NP | denotes | cultured endothelial cells |
| C11 | 556-596 | NP | denotes | binding to cell-surface heparan sulphate |
| C12 | 634-643 | NP | denotes | IFN-gamma |
| C13 | 653-665 | NP | denotes | free heparin |
| C14 | 689-715 | NP | denotes | this sequestration process |
| C15 | 816-823 | NP | denotes | heparin |
| C16 | 899-937 | NP | denotes | monocyte chemotactic peptide-1 (MCP-1) |
| C17 | 939-1026 | NP | denotes | a chemokine important for mononuclear leucocyte recruitment across vascular endothelium |
| C18 | 1057-1064 | NP | denotes | heparin |
| C19 | 1070-1079 | NP | denotes | IFN-gamma |
| C20 | 1233-1242 | NP | denotes | IFN-gamma |
| C22 | 1261-1277 | NP | denotes | MCP-1 production |
| C21 | 1244-1277 | NP | denotes | An inhibition of MCP-1 production |
| C23 | 1291-1295 | NP | denotes | that |
| C24 | 1334-1343 | NP | denotes | IFN-gamma |
| C25 | 1349-1399 | NP | denotes | heparin-like, and therefore cytokine-binding, GAGs |
| C26 | 1435-1452 | NP | denotes | heparin-like GAGs |
| C27 | 1458-1463 | NP | denotes | MCP-1 |
| C28 | 1474-1541 | NP | denotes | the rapid tyrosine phosphorylation of phosphatidylinositol 3-kinase |
| C29 | 1542-1547 | NP | denotes | which |
| C30 | 1613-1627 | NP | denotes | this chemokine |
| C31 | 1767-1772 | NP | denotes | MCP-1 |
| C32 | 1812-1838 | NP | denotes | soluble, heparin-like GAGs |
| C33 | 1886-1902 | NP | denotes | MCP-1 production |
| C34 | 1906-1932 | NP | denotes | cultured endothelial cells |
| C35 | 2021-2039 | NP | denotes | pre-existing MCP-1 |
| C36 | 2111-2118 | NP | denotes | heparin |
| R1 | C3 | C2 | coref-ident | Heparin,heparin |
| R2 | C6 | C5 | coref-relat | that,a polyanionic glycosaminoglycan (GAG) |
| R3 | C8 | C4 | coref-ident | This GAG,a polyanionic glycosaminoglycan (GAG) that can bind with high affinity to a range of cytokines including interferon-gamma (IFN-gamma) and members of the chemokine superfamily |
| R4 | C9 | C7 | coref-ident | IFN-gamma,interferon-gamma (IFN-gamma) |
| R5 | C12 | C9 | coref-ident | IFN-gamma,IFN-gamma |
| R6 | C13 | C3 | coref-ident | free heparin,Heparin |
| R7 | C14 | C11 | coref-ident | this sequestration process,binding to cell-surface heparan sulphate |
| R8 | C15 | C13 | coref-ident | heparin,free heparin |
| R9 | C16 | C1 | coref-ident | monocyte chemotactic peptide-1 (MCP-1),MCP-1 |
| R10 | C17 | C16 | coref-appos | a chemokine important for mononuclear leucocyte recruitment across vascular endothelium,monocyte chemotactic peptide-1 (MCP-1) |
| R11 | C18 | C15 | coref-ident | heparin,heparin |
| R12 | C19 | C12 | coref-ident | IFN-gamma,IFN-gamma |
| R13 | C20 | C19 | coref-ident | IFN-gamma,IFN-gamma |
| R14 | C23 | C21 | coref-relat | that,An inhibition of MCP-1 production |
| R15 | C24 | C20 | coref-ident | IFN-gamma,IFN-gamma |
| R16 | C26 | C25 | coref-ident | heparin-like GAGs,"heparin-like, and therefore cytokine-binding, GAGs" |
| R17 | C27 | C16 | coref-ident | MCP-1,monocyte chemotactic peptide-1 (MCP-1) |
| R18 | C29 | C28 | coref-relat | which,the rapid tyrosine phosphorylation of phosphatidylinositol 3-kinase |
| R19 | C30 | C27 | coref-ident | this chemokine,MCP-1 |
| R20 | C31 | C30 | coref-ident | MCP-1,this chemokine |
| R21 | C32 | C26 | coref-ident | "soluble, heparin-like GAGs",heparin-like GAGs |
| R22 | C33 | C22 | coref-ident | MCP-1 production,MCP-1 production |
| R23 | C34 | C10 | coref-ident | cultured endothelial cells,cultured endothelial cells |
| R24 | C35 | C31 | coref-ident | pre-existing MCP-1,MCP-1 |
| R25 | C36 | C18 | coref-ident | heparin,heparin |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-104 | Sentence | denotes | Endothelial production of MCP-1: modulation by heparin and consequences for mononuclear cell activation. |
| S2 | 105-291 | Sentence | denotes | Heparin is a polyanionic glycosaminoglycan (GAG) that can bind with high affinity to a range of cytokines including interferon-gamma (IFN-gamma) and members of the chemokine superfamily. |
| S3 | 292-522 | Sentence | denotes | This GAG also possesses immunomodulatory activity in vivo and can antagonize the capacity of IFN-gamma to induce class II MHC antigen expression, and to up-regulate intercellular adhesion molecule-1, by cultured endothelial cells. |
| S4 | 523-716 | Sentence | denotes | Previous studies have shown that binding to cell-surface heparan sulphate is essential for optimal activity of IFN-gamma and that free heparin competitively inhibits this sequestration process. |
| S5 | 717-1027 | Sentence | denotes | The present study was performed to increase our understanding of the immunosuppressive activity of heparin by investigation of potential antagonism of the production and function of monocyte chemotactic peptide-1 (MCP-1), a chemokine important for mononuclear leucocyte recruitment across vascular endothelium. |
| S6 | 1028-1243 | Sentence | denotes | It was found that mixture of heparin with IFN-gamma inhibited up-regulation of the signal transducer and activator of transcription protein, STAT-1 produced normally by treatment of endothelial cells with IFN-gamma. |
| S7 | 1244-1400 | Sentence | denotes | An inhibition of MCP-1 production was observed that was specifically caused by mixture of IFN-gamma with heparin-like, and therefore cytokine-binding, GAGs. |
| S8 | 1401-1628 | Sentence | denotes | It was also shown that mixture of heparin-like GAGs with MCP-1 inhibited the rapid tyrosine phosphorylation of phosphatidylinositol 3-kinase which is normally produced by treatment of mononuclear leucocytes with this chemokine. |
| S9 | 1629-1773 | Sentence | denotes | Blockade of this intracellular signalling event was associated with a reduction in the normal transendothelial migration response towards MCP-1. |
| S10 | 1774-2040 | Sentence | denotes | Results from this study indicate that soluble, heparin-like GAGs can block IFN-gamma-dependent up-regulation of MCP-1 production by cultured endothelial cells, and can also antagonize the leucocyte-activating and migration-promoting properties of pre-existing MCP-1. |
| S11 | 2041-2119 | Sentence | denotes | These activities may contribute to the immunomodulatory properties of heparin. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-22 | other_name | denotes | Endothelial production |
| T2 | 26-31 | protein_molecule | denotes | MCP-1 |
| T3 | 47-54 | other_organic_compound | denotes | heparin |
| T4 | 76-103 | other_name | denotes | mononuclear cell activation |
| T5 | 105-112 | other_organic_compound | denotes | Heparin |
| T6 | 118-147 | other_organic_compound | denotes | polyanionic glycosaminoglycan |
| T7 | 149-152 | other_organic_compound | denotes | GAG |
| T8 | 201-210 | protein_family_or_group | denotes | cytokines |
| T9 | 221-237 | protein_molecule | denotes | interferon-gamma |
| T10 | 239-248 | protein_molecule | denotes | IFN-gamma |
| T11 | 269-290 | protein_family_or_group | denotes | chemokine superfamily |
| T12 | 297-300 | other_organic_compound | denotes | GAG |
| T13 | 316-341 | other_name | denotes | immunomodulatory activity |
| T14 | 385-394 | protein_molecule | denotes | IFN-gamma |
| T15 | 405-425 | protein_family_or_group | denotes | class II MHC antigen |
| T16 | 457-490 | protein_molecule | denotes | intercellular adhesion molecule-1 |
| T17 | 495-521 | cell_line | denotes | cultured endothelial cells |
| T18 | 567-596 | other_organic_compound | denotes | cell-surface heparan sulphate |
| T19 | 614-630 | other_name | denotes | optimal activity |
| T20 | 634-643 | protein_molecule | denotes | IFN-gamma |
| T21 | 658-665 | other_organic_compound | denotes | heparin |
| T22 | 694-715 | other_name | denotes | sequestration process |
| T23 | 786-812 | other_name | denotes | immunosuppressive activity |
| T24 | 816-823 | other_organic_compound | denotes | heparin |
| T25 | 899-929 | protein_molecule | denotes | monocyte chemotactic peptide-1 |
| T26 | 931-936 | protein_molecule | denotes | MCP-1 |
| T27 | 941-950 | protein_family_or_group | denotes | chemokine |
| T28 | 965-998 | other_name | denotes | mononuclear leucocyte recruitment |
| T29 | 1006-1026 | tissue | denotes | vascular endothelium |
| T30 | 1057-1064 | other_organic_compound | denotes | heparin |
| T31 | 1070-1079 | protein_molecule | denotes | IFN-gamma |
| T32 | 1169-1175 | protein_molecule | denotes | STAT-1 |
| T33 | 1210-1227 | cell_type | denotes | endothelial cells |
| T34 | 1233-1242 | protein_molecule | denotes | IFN-gamma |
| T35 | 1261-1266 | protein_molecule | denotes | MCP-1 |
| T36 | 1334-1343 | protein_molecule | denotes | IFN-gamma |
| T37 | 1435-1442 | other_organic_compound | denotes | heparin |
| T38 | 1458-1463 | protein_molecule | denotes | MCP-1 |
| T39 | 1484-1492 | amino_acid_monomer | denotes | tyrosine |
| T40 | 1512-1541 | protein_molecule | denotes | phosphatidylinositol 3-kinase |
| T41 | 1585-1607 | cell_type | denotes | mononuclear leucocytes |
| T42 | 1618-1627 | protein_family_or_group | denotes | chemokine |
| T43 | 1646-1676 | other_name | denotes | intracellular signalling event |
| T44 | 1716-1749 | other_name | denotes | normal transendothelial migration |
| T45 | 1767-1772 | protein_molecule | denotes | MCP-1 |
| T46 | 1821-1828 | other_organic_compound | denotes | heparin |
| T47 | 1849-1858 | protein_molecule | denotes | IFN-gamma |
| T48 | 1886-1891 | protein_molecule | denotes | MCP-1 |
| T49 | 1906-1914 | cell_line | denotes | cultured |
| T50 | 1915-1932 | cell_type | denotes | endothelial cells |
| T51 | 1962-2017 | other_name | denotes | leucocyte-activating and migration-promoting properties |
| T52 | 2034-2039 | protein_molecule | denotes | MCP-1 |
| T53 | 2080-2107 | other_name | denotes | immunomodulatory properties |
| T54 | 2111-2118 | other_organic_compound | denotes | heparin |